The macrophage Repairome
The macrophage Repairome
批准号:
10448493
负责人:
Stephanie M M Seveau
金额:
$7.88万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-07-12 至 2024-06-30
关键词:
Bacterial ToxinsBindingCRISPR libraryCRISPR screenCRISPR/Cas technologyCandidate Disease GeneCell LineCell MaintenanceCell SeparationCell membraneCellsChimeric ProteinsCholesterolCommunicable DiseasesComplexCytosolDefense MechanismsDevelopmentExposure toFamilyFluorescenceFluorescent DyesFundingFutureGenerationsGenesGenomic DNAGenomic LibraryGoalsGram-Positive BacteriaGrantGuide RNAHomeostasisHospitalizationHumanImmuneImmune responseImmunityInfectionKnock-outLibrariesListeria monocytogenesListeria monocytogenes hlyA proteinListeriosisLiteratureMembraneMethodsMicrobeOntologyOutcomePathogenesisPathway AnalysisPathway interactionsPerforationPhagosomesPharmacologyPhenotypePlasma CellsPlayPopulationProteinsResearchRoleSmall Interfering RNATargeted ToxinsTherapeutic InterventionToxinValidationVirulence FactorsWorkantimicrobialbasecell injurycostdeep sequencingexperiencefoodborne pathogengenome editinggenome-wideinhibitorlive cell imagingmacrophagemonocytenew therapeutic targetnext generation sequencingnovelpathogenpathogenic bacteriapreventrepairedscreeningspatiotemporaltherapeutic developmenttoolwhole genome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Summary
Plasma membrane disruption by pore-forming toxins (PFTs) is a most common and ancient strategy used by
bacterial pathogens to infect their host and evade the host’s immune responses. Listeriolysin O (LLO) is a PFT
produced by the foodborne pathogen Listeria monocytogenes (Lm). Lm is a Gram-positive bacterium responsible
for listeriosis, a severe illness leading to 99% hospitalization and up to 30% fatality despite treatment. Lm is a
facultative intracellular pathogen that infects a large array of cells including macrophages. Although Lm produces
numerous virulence factors, LLO is uniquely known to be indispensable for pathogenesis. Therefore, LLO and
the host pathways targeted by this toxin are promising targets for the development of therapeutic interventions.
LLO is secreted at all stages of the Lm intracellular lifecycle and binds cholesterol to assemble a large
transmembrane pore complex. This virulence factor has long been known to perforate the membrane of the Lm-
containing phagosome to release Lm into its replicative niche, the cytosol. It was recently established that LLO
also perforates the host cell plasma membrane, which facilitates cell invasion and phagosomal escape.
Monocyte/Macrophages, which specialize in the capture and destruction of microbes, evolved cytoprotective
mechanisms (referred to as the macrophage repairome) to maintain cell homeostasis and survival despite LLO
attack. How macrophages repair their plasma membrane and prevent toxin attack is not fully understood. The
goal of this R03 proposal is to develop tools to discover the “macrophage repairome” using unbiased whole-
genome screening. Our lab successfully developed fluorescence-based screening methods to analyze the repair
machineries of cells exposed to LLO. To establish the macrophage repairome in an unbiased fashion, we will
perform a whole-genome screen using CRISPR/Cas9 genome editing. We will generate a CRISPR/Cas9 library
in THP-1 cells (human monocyte-like cell line) and screen the library for cells unable to maintain their integrity
upon LLO exposure using florescence-activated cell sorting (FACS)-selectable phenotype (positive screen).
Indeed, damaged cells with deficient cell repair will be fluorescent, whereas intact cells will exclude the
fluorescent dye. Deep sequencing will generate a list of candidate genes required for maintaining macrophage
integrity. We will perform pathway analysis, select the most novel and promising pathways, and validate the
selected pathways in THP-1 cells. These pathways will be studied in detail in the context of L. monocytogenes
infection via future R01 funding. Understanding the mechanisms used by macrophages to counteract bacterial
pore-forming toxins is expected to facilitate the development of novel antimicrobial treatments to alleviate the
burden of infectious diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The macrophage Repairome
-
批准号:10294333
-
项目类别:
-
资助金额:$7.88万
-
财政年份:2021
-
负责人:Stephanie M M Seveau
-
依托单位:
Establishing the roles of lncRNAs in placental infection by Listeria monocytogenes
-
批准号:10092106
-
项目类别:
-
资助金额:$7.8万
-
财政年份:2020
-
负责人:Stephanie M M Seveau
-
依托单位:
Mechanistic study of human placental infection by Listeria monocytogenes
-
批准号:8701610
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2014
-
负责人:Stephanie M M Seveau
-
依托单位:
Multifaceted activity of listeriolysin O during host cell invasion by Listeria
-
批准号:8698060
-
项目类别:
-
资助金额:$37.32万
-
财政年份:2014
-
负责人:Stephanie M M Seveau
-
依托单位:
Multifaceted activity of listeriolysin O during host cell invasion by Listeria
-
批准号:8793094
-
项目类别:
-
资助金额:$37.63万
-
财政年份:2014
-
负责人:Stephanie M M Seveau
-
依托单位:
Multifaceted activity of listeriolysin O during host cell invasion by Listeria
-
批准号:9206879
-
项目类别:
-
资助金额:$38.33万
-
财政年份:2014
-
负责人:Stephanie M M Seveau
-
依托单位:
Mechanistic study of human placental infection by Listeria monocytogenes
-
批准号:8915036
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2014
-
负责人:Stephanie M M Seveau
-
依托单位:
Multifaceted activity of listeriolysin O during host cell invasion by Listeria
-
批准号:8995618
-
项目类别:
-
资助金额:$38.06万
-
财政年份:2014
-
负责人:Stephanie M M Seveau
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: